BioBridgeXAll companies

ImmunoMolecular Therapeutics, Inc.

Biotechnology company · Woburn, Massachusetts, United States

ImmunoMolecular Therapeutics, Inc. is a biotechnology company headquartered in Woburn, Massachusetts, United States. Its earliest recorded incorporation is in 2015. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $224,991 in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $7 million sold in a notice filed in 2020.

www.imtherapeutics.comProfile compiled from public records. Is this your company? Request a correction or update

ImmunoMolecular Therapeutics at a glance

Typebiotechnology company
HeadquartersWoburn, Massachusetts, United States
Earliest incorporation on record2015
Employees (self-reported, 2018)3
SEC CIK1646606

What does ImmunoMolecular Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $224,991 in total (2018). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $7 million sold (2020).

Frequently asked questions about ImmunoMolecular Therapeutics

Where is ImmunoMolecular Therapeutics headquartered?

ImmunoMolecular Therapeutics, Inc. is headquartered in Woburn, Massachusetts, United States.

What does ImmunoMolecular Therapeutics do?

ImmunoMolecular Therapeutics, Inc. is a biotechnology company.

When was ImmunoMolecular Therapeutics founded?

The earliest incorporation on record for ImmunoMolecular Therapeutics, Inc. is in 2015, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences